Abstract:Selective inhibition of cancer cells remains a challenge in chemotherapy. Here we report the molecular and cellular validation of enzyme-instructed self-assembly (EISA) as a multiple step process for selectively killing cancer cells that overexpress alkaline phosphatases (ALPs). We design and synthesize two kinds of D-tetrapeptide containing one or two phosphotyrosine residues and with the N-terminal capped by a naphthyl group. Upon enzymatic dephosphorylation, these D-tetrapeptides turn into self-assembling molecules to form nanofibers in water. Incubating these D-tetrapeptides with several cancer cell lines and one normal cell line, the unphosphorylated D-tetrapeptides are innocuous to all the cell lines, the mono- and diphosphorylated D-tetrapeptides selectively inhibit the cancer cells, but not the normal cell. The monophosphorylated D-tetrapeptides exhibit more potent inhibitory activity than the diphosphorylated D-tetrapeptides do; the cancer cell lines express higher level of ALPs are more susceptible to inhibition by the phosphorylated D-tetrapeptides; the precursors of D-tetrapeptides that possess higher self-assembling abilities exhibit higher inhibitory activities. These results confirm the important role of enzymatic reaction and self-assembly. Using uncompetitive inhibitors of ALPs and fluorescent D-tetrapeptides, we delineate that the enzyme catalyzed dephosphorylation and the self-assembly steps, together, result in the localization of the nanofibers of D-tetrapeptides for killing the cancer cells. We find that the cell death modality likely associates with the cell type and prove the interactions between nanofibers and the death receptors. This work illustrates a paradigm shifting and biomimetic approach and contributes useful molecular insights for the development of spatiotemporal defined supramolecular processes/assemblies as potential anticancer therapeutics.

Enzyme-assisted peptide folding, assembly and anti-cancer properties.

Revealing the Self-Assembly Pathways and Nanomechanics of Enzyme-Triggered Nanofibers from Peptide Amphiphiles for Cancer Theranostics

Supramolecular nanofibers with superior anti-angiogenesis and antitumor properties by enzyme-instructed self-assembly (EISA)

Enzyme‐Instructed Supramolecular Self‐Assembly with Anticancer Activity

Enhanced Cellular Uptake and Nuclear Accumulation of Drug-Peptide Nanomedicines Prepared by Enzyme-Instructed Self-Assembly.

Enzyme-Instructed Self-Assembly Of Small D-Peptides As A Multiple-Step Process For Selectively Killing Cancer Cells

Preorganization Increases the Self-Assembling Ability and Antitumor Efficacy of Peptide Nanomedicine.

In Vivo Self-Sorting of Peptides via In Situ Assembly Evolution

Supramolecular Nanofibers with Superior Bioactivity to Insulin-Like Growth Factor-I.

Controlled Assembly and Disassembly of Higher-Order Peptide Nanotubes.

Enzyme-Instructed Self-Assembly Of Small Peptides In Vivo For Biomedical Application

Conformation Influences Biological Fates of Peptide‐Based Nanofilaments by Modulating Protein Adsorption and Interfilament Entanglement

Enzyme-instructed Self-Assembly: a Multistep Process for Potential Cancer Therapy.

Enzyme-Instructed Peptide Assembly Favored by Preorganization for Cancer Cell Membrane Engineering.

Enzyme‐Instructed Self‐Assembly (EISA) and Hydrogelation of Peptides

In situ AFM investigation of dual-mode self-assembling peptide

Enzyme-Instructed Self-Assembly of Peptide Derivatives to Form Nanofibers and Hydrogels

Enzyme-Triggered Morphological Transition of Peptide Nanostructures for Tumor-Targeted Drug Delivery and Enhanced Cancer Therapy.

Engineering and Preliminary Evaluation of Multiple Non-Equilibrium Nanostructures from a Single Peptide Amphiphile

Integration of Enzymatic Transformation and Self‐Assembly for Future Cancer Therapy

Principles Governing Catalytic Activity of Self-Assembled Short Peptides